why choose us

300×250 Ad Slot

Research Article: Feasibility and Tolerability of Anlotinib Plus PD- Blockades for Patients with Treatment-Refractory Metastatic Colorectal Cancer: A Retrospective Exploratory Study

Date Published: 2024-02-01

Introduction:
Colorectal cancer (CRC) was one of the most common gastrointestinal cancer globally, and the incidence of CRC increased dramatically. It was estimated that there were approximately . million new cases and . million new deaths each year worldwide in . Currently, it was estimated that about . million new cases and . new deaths of CRC were observed in China in . Although surgical resection was the only way to cure patients with early-stage CRC, approximately a quarter of the patients were diagnosed with distant…

Read more

300×250 Ad Slot